3 results
The objective of this extension study is to assess the long-term safety and efficacy of Myozyme treatment in patients with Late-Onset Pompe Disease who were previously treated under the placebo-controlled, double-blind study AGLU02704.
This imaging methodology will allow an assessment of the extent of airway changes using a triple combination of Budesonide/Glycopyrronium/Formoterol Fumarate (BGF) and the dual combination Glycopyrronium/Formoterol Fumarate (GFF).
The main goal of this study is to determine whether the CGM can replace venipunctures to measure blood glucose values during the oGTT.The second goal of this study is to investigate to what extent glucose profiles, measured at home using the CGM,…